Pallas Capital Advisors »

United Therapeutics Corporation shares owned by Pallas Capital Advisors

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Pallas Capital Advisors from 13F filings

Historical chart of Pallas Capital Advisors investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Pallas Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Pallas Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.0M 4.1k 487.25
2025-09-30 $694k 1.7k 419.21
2025-06-30 $527k 1.8k 287.35
2025-03-31 $351k 1.1k 308.27
2024-12-31 $632k 1.8k 352.84
2024-09-30 $664k 1.9k 350.19
2024-06-30 $383k 1.2k 328.67
2024-03-31 $228k 991 229.72

More positions owned by Pallas Capital Advisors

Bruker Corporation (BRKR)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Microsoft Corporation (MSFT)
Global Partners Com Units (GLP)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Schwab Strategic Tr Fundamental Intl (FNDF)
Dimensional Etf Trust Internatnal Val (DFIV)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Broadcom (AVGO)
Fidelity Covington Trust Enhanced Intl (FENI)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)

View all positions for Pallas Capital Advisors

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Invesco
Assetmark
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation